{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:30:19Z","timestamp":1792708219994,"version":"4.5.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373894"],"award-info":[{"award-number":["82373894"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","award":["2025JC-YBMS-183"],"award-info":[{"award-number":["2025JC-YBMS-183"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.intimp.2025.115013","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T05:25:34Z","timestamp":1749705934000},"page":"115013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The role of tumor-associated endothelial cells in malignant progression and immune evasion of liver cancer"],"prefix":"10.1016","volume":"161","author":[{"given":"Shuangpeng","family":"Pu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianguang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115013_bb0005","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13046-018-0777-4","article-title":"Immune checkpoint therapy in liver cancer","volume":"37","author":"Xu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2025.115013_bb0010","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","article-title":"Management of Hepatocellular Carcinoma: a review","volume":"158","author":"Brown","year":"2023","journal-title":"JAMA Surg."},{"key":"10.1016\/j.intimp.2025.115013_bb0015","first-page":"14","article-title":"Emerging therapies for hepatocellular carcinoma (HCC)","author":"Chakraborty","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2025.115013_bb0020","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1097\/00004836-200411003-00008","article-title":"Global epidemiology of hepatitis B virus","volume":"38","author":"Custer","year":"2004","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.intimp.2025.115013_bb0025","doi-asserted-by":"crossref","first-page":"1133308","DOI":"10.3389\/fimmu.2023.1133308","article-title":"Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115013_bb0030","first-page":"14","article-title":"The tumor microenvironment of hepatocellular carcinoma: untying an intricate immunological network","author":"Volponi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2025.115013_bb0035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40164-024-00539-x","article-title":"Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside","volume":"13","author":"Yin","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2025.115013_bb0040","first-page":"13","article-title":"Interplay between cellular and non-cellular components of the tumour microenvironment in hepatocellular carcinoma","author":"S\u00fckei","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2025.115013_bb0045","doi-asserted-by":"crossref","first-page":"nwae231","DOI":"10.1093\/nsr\/nwae231","article-title":"Pan-cancer integrative analyses dissect the remodeling of endothelial cells in human cancers","volume":"11","author":"Li","year":"2024","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.intimp.2025.115013_bb0050","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jcmgh.2020.12.007","article-title":"Single-cell transcriptomics reveals zone-specific alterations of liver sinusoidal endothelial cells in cirrhosis","volume":"11","author":"Su","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2025.115013_bb0055","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1158\/0008-5472.CAN-20-0242","article-title":"YAP orchestrates heterotypic endothelial cell communication via HGF\/c-MET Signaling in liver tumorigenesis","volume":"80","author":"Thomann","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2025.115013_bb0060","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41568-023-00591-5","article-title":"Understanding tumour endothelial cell heterogeneity and function from single-cell omics","volume":"23","author":"Zeng","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2025.115013_bb0065","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41575-018-0020-y","article-title":"Liver sinusoidal endothelial cells-gatekeepers of hepatic immunity","volume":"15","author":"Shetty","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2025.115013_bb0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.intimp.2025.115013_bb0075","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1158\/0008-5472.CAN-19-3791","article-title":"Chemotherapy-induced IL8 upregulates MDR1\/ABCB1 in tumor blood vessels and results in Unfavorable outcome","volume":"80","author":"Kikuchi","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2025.115013_bb0080","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature21065","article-title":"Single-cell spatial reconstruction reveals global division of labour in the mammalian liver","volume":"542","author":"Halpern","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.115013_bb0085","doi-asserted-by":"crossref","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","article-title":"The liver","volume":"27","author":"Trefts","year":"2017","journal-title":"Curr. Biol."},{"key":"10.1016\/j.intimp.2025.115013_bb0090","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/HEP.0000000000000207","article-title":"The evolving role of liver sinusoidal endothelial cells in liver health and disease","volume":"78","author":"McConnell","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2025.115013_bb0095","doi-asserted-by":"crossref","unstructured":"Augustin H. G., Kozian D. H., Johnson R. C.: Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes. Bioessays 1994, 16:901\u2013906. doi: https:\/\/doi.org\/10.1002\/bies.950161208]https:\/\/doi.org\/10.1002\/bies.950161208].","DOI":"10.1002\/bies.950161208"},{"key":"10.1016\/j.intimp.2025.115013_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002281","article-title":"Rapid and efficient clearance of blood-borne virus by liver sinusoidal endothelium","volume":"7","author":"Ganesan","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2025.115013_bb0105","article-title":"Endothelial RUNX3 controls LSEC dysfunction and angiocrine LRG1 signaling to prevent liver fibrosis","author":"Ojha","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2025.115013_bb0110","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.stem.2022.04.008","article-title":"The spatiotemporal program of zonal liver regeneration following acute injury","volume":"29","author":"Ben-Moshe","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.intimp.2025.115013_bb0115","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1038\/s41467-018-06318-7","article-title":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations","volume":"9","author":"MacParland","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.115013_bb0120","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.115013_bb0125","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ccell.2018.07.009","article-title":"Notch Signaling in the tumor microenvironment","volume":"34","author":"Meurette","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2025.115013_bb0130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000109079","article-title":"Phenotypic and functional differences between human liver cancer endothelial cells and liver sinusoidal endothelial cells","volume":"45","author":"Wu","year":"2008","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.intimp.2025.115013_bb0135","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.bbrc.2010.03.089","article-title":"Isolated tumor endothelial cells maintain specific character during long-term culture","volume":"394","author":"Matsuda","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2025.115013_bb0140","article-title":"CXCL12(+) tumor-associated endothelial cells promote immune resistance in hepatocellular carcinoma","author":"Lu","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2025.115013_bb0145","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ccell.2016.10.006","article-title":"Inhibition of the glycolytic activator PFKFB3 in endothelium induces tumor vessel normalization, impairs metastasis, and improves chemotherapy","volume":"30","author":"Cantelmo","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2025.115013_bb0150","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cmet.2018.06.009","article-title":"Serine synthesis via PHGDH is essential for Heme production in endothelial cells","volume":"28","author":"Vandekeere","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2025.115013_bb0155","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cell.2013.06.037","article-title":"Role of PFKFB3-driven glycolysis in vessel sprouting","volume":"154","author":"De Bock","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.115013_bb0160","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/ATVBAHA.113.303041","article-title":"Endothelial PFKFB3 plays a critical role in angiogenesis","volume":"34","author":"Xu","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2025.115013_bb0165","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.15252\/embj.201695518","article-title":"Role of glutamine and interlinked asparagine metabolism in vessel formation","volume":"36","author":"Huang","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.intimp.2025.115013_bb0170","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","article-title":"Glutamine reliance in cell metabolism","volume":"52","author":"Yoo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2025.115013_bb0175","article-title":"The influence of endothelial metabolic reprogramming on the tumor microenvironment","author":"Kane","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2025.115013_bb0180","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s42003-023-05455-0","article-title":"Single-cell and spatial architecture of primary liver cancer","volume":"6","author":"Zhou","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.intimp.2025.115013_bb0185","doi-asserted-by":"crossref","first-page":"18799","DOI":"10.1038\/s41598-023-46132-w","article-title":"Single-cell RNA sequencing revealed potential targets for immunotherapy studies in hepatocellular carcinoma","volume":"13","author":"Xie","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2025.115013_bb0190","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-024-01828-x","article-title":"Notch signaling pathway in cancer: from mechanistic insights to targeted therapies","volume":"9","author":"Shi","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2025.115013_bb0195","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.150155","article-title":"Notch stimulates growth by direct regulation of genes involved in the control of glycolysis and the tricarboxylic acid cycle","volume":"6","author":"Slaninova","year":"2016","journal-title":"Open Biol."},{"key":"10.1016\/j.intimp.2025.115013_bb0200","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41401-021-00647-y","article-title":"The glycolytic process in endothelial cells and its implications","volume":"43","author":"Leung","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2025.115013_bb0205","first-page":"13","article-title":"Targeting mTOR and glycolysis in HER2-positive breast Cancer","author":"Holloway","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2025.115013_bb0210","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12967-024-04947-9","article-title":"Integrative single-cell transcriptomic analyses reveal the cellular ontological and functional heterogeneities of primary and metastatic liver tumors","volume":"22","author":"Gui","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2025.115013_bb0215","article-title":"CD34+CLDN5+ tumor associated senescent endothelial cells through IGF2-IGF2R signaling increased cholangiocellular phenotype in hepatocellular carcinoma","author":"Zhu","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.intimp.2025.115013_bb0220","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cell.2020.08.040","article-title":"Onco-fetal reprogramming of endothelial cells drives immunosuppressive macrophages in hepatocellular carcinoma","volume":"183","author":"Sharma","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.115013_bb0225","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s42003-023-05455-0","article-title":"Single-cell and spatial architecture of primary liver cancer","volume":"6","author":"Zhou","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.intimp.2025.115013_bb0230","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.18362","article-title":"Exploring tumor endothelial cells heterogeneity in hepatocellular carcinoma: insights from single-cell sequencing and pseudotime analysis","volume":"12","author":"Sun","year":"2024","journal-title":"PeerJ"},{"key":"10.1016\/j.intimp.2025.115013_bb0235","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.7150\/ijbs.82317","article-title":"CXCL12-CXCR4\/CXCR7 Axis in Cancer: from mechanisms to clinical applications","volume":"19","author":"Yang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2025.115013_bb0240","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/B978-0-12-411638-2.00002-1","article-title":"The intricate role of CXCR4 in cancer","volume":"124","author":"Chatterjee","year":"2014","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.intimp.2025.115013_bb0245","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.2174\/0929867324666170830111531","article-title":"Targeting CXCL12\/CXCR4 Axis in tumor immunotherapy","volume":"26","author":"Zhou","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.intimp.2025.115013_bb0250","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1111\/j.1582-4934.2010.01191.x","article-title":"The relationship between early embryo development and tumourigenesis","volume":"14","author":"Ma","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.intimp.2025.115013_bb0255","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000217555","article-title":"Immunohistochemistry of carcino-embryonic antigen in the embryo, fetus and adult","volume":"9","author":"Nap","year":"1988","journal-title":"Tumour Biol."},{"key":"10.1016\/j.intimp.2025.115013_bb0260","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1615\/CritRevEukarGeneExpr.v7.i1-2.20","article-title":"Regulation and activities of alpha-fetoprotein","volume":"7","author":"Chen","year":"1997","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.intimp.2025.115013_bb0265","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00441-023-03741-1","article-title":"The role of PLVAP in endothelial cells","volume":"392","author":"Denzer","year":"2023","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.intimp.2025.115013_bb0270","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature19814","article-title":"Fetal liver endothelium regulates the seeding of tissue-resident macrophages","volume":"538","author":"Rantakari","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.115013_bb0275","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1038\/s41388-021-01844-z","article-title":"Plasmalemma vesicle-associated protein promotes angiogenesis in cholangiocarcinoma via the DKK1\/CKAP4\/PI3K signaling pathway","volume":"40","author":"Wang","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2025.115013_bb0280","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/path.1805","article-title":"Plasmalemmal vesicle-associated protein (PLVAP) is expressed by tumour endothelium and is upregulated by vascular endothelial growth factor-a (VEGF)","volume":"206","author":"Strickland","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.intimp.2025.115013_bb0285","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1186\/1471-2407-14-815","article-title":"Plasmalemmal vesicle associated protein (PLVAP) as a therapeutic target for treatment of hepatocellular carcinoma","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.intimp.2025.115013_bb0290","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1262-3636(07)70133-7","article-title":"Role of the liver in the control of carbohydrate and lipid homeostasis","volume":"30","author":"Postic","year":"2004","journal-title":"Diabetes Metab."},{"issue":"335\u2013350","key":"10.1016\/j.intimp.2025.115013_bb0295","first-page":"vi","article-title":"The insulin-like growth factor system in cancer","volume":"41","author":"Weroha","year":"2012","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.intimp.2025.115013_bb0300","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.3892\/ijo.2012.1666","article-title":"The insulin-like growth factor (IGF) signaling axis and hepatitis C virus-associated carcinogenesis (review)","volume":"41","author":"Kasprzak","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2025.115013_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097136","article-title":"HCC development is associated to peripheral insulin resistance in a mouse model of NASH","volume":"9","author":"De Minicis","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2025.115013_bb0310","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/(SICI)1098-2744(199704)18:4<193::AID-MC2>3.0.CO;2-F","article-title":"Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma","volume":"18","author":"Uchida","year":"1997","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.intimp.2025.115013_bb0315","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0304-3835(98)00044-5","article-title":"Insulin-like growth factor II (IGF-II) secreted from HepG2 human hepatocellular carcinoma cells shows angiogenic activity","volume":"128","author":"Bae","year":"1998","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2025.115013_bb0320","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1054\/ghir.2002.0261","article-title":"Diethylnitrosamine induces long-lasting re-expression of insulin-like growth factor II during early stages of liver carcinogenesis in mice","volume":"12","author":"Lahm","year":"2002","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.intimp.2025.115013_bb0325","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.115013_bb0330","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.115013_bb0335","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2025.115013_bb0340","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1158\/1078-0432.CCR-16-3171","article-title":"Phase I and preliminary phase II study of TRC105 in combination with sorafenib in hepatocellular carcinoma","volume":"23","author":"Duffy","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2025.115013_bb0345","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1002\/cncr.26556","article-title":"Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer","volume":"118","author":"Philip","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.intimp.2025.115013_bb0350","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000324704","article-title":"Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results?","volume":"80","author":"Kemeny","year":"2011","journal-title":"Oncology"},{"key":"10.1016\/j.intimp.2025.115013_bb0355","doi-asserted-by":"crossref","first-page":"1846926","DOI":"10.1080\/2162402X.2020.1846926","article-title":"Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trial","volume":"9","author":"Dai","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.intimp.2025.115013_bb0360","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jhep.2012.01.006","article-title":"Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma","volume":"56","author":"Park","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.intimp.2025.115013_bb0365","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2025.115013_bb0370","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1093\/annonc\/mdv388","article-title":"Randomized phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma","volume":"26","author":"Kang","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.intimp.2025.115013_bb0375","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1586\/14737140.9.2.247","article-title":"mTOR inhibitors for hepatocellular cancer: a forward-moving target","volume":"9","author":"Treiber","year":"2009","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.intimp.2025.115013_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102017","article-title":"Bevacizumab (Avastin\u00ae) in cancer treatment: a review of 15 years of clinical experience and future outlook","volume":"86","author":"Garcia","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.intimp.2025.115013_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109253","article-title":"Tumor vessel co-option probed by single-cell analysis","volume":"35","author":"Teuwen","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2025.115013_bb0390","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.canlet.2021.08.028","article-title":"Sunitinib increases the cancer stem cells and vasculogenic mimicry formation via modulating the lncRNA-ECVSR\/ER\u03b2\/Hif2-\u03b1 signaling","volume":"524","author":"He","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2025.115013_bb0395","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2025.115013_bb0400","first-page":"23","article-title":"Novel drugs with high efficacy against tumor angiogenesis","author":"Qi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115013_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105010","article-title":"CXCR4 antagonist AMD3100 (plerixafor): from an impurity to a therapeutic agent","volume":"159","author":"Wang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2025.115013_bb0410","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/s41416-020-0774-1","article-title":"Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours","volume":"122","author":"de Bono","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2025.115013_bb0415","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/ijc.22024","article-title":"Chemokines and cancer","volume":"119","author":"Zlotnik","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2025.115013_bb0420","first-page":"11","article-title":"IGF2: development, genetic and epigenetic abnormalities","author":"S\u00e9l\u00e9nou","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2025.115013_bb0425","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-021-00496-y","article-title":"Anti-angiogenic agents-overcoming tumour endothelial cell anergy and improving immunotherapy outcomes","volume":"18","author":"Huinen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.intimp.2025.115013_bb0430","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm0901-987","article-title":"Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy","volume":"7","author":"Jain","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2025.115013_bb0435","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.115013_bb0440","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41591-023-02275-x","article-title":"Pembrolizumab and Cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial","volume":"29","author":"Saba","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2025.115013_bb0445","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s40820-020-00482-6","article-title":"A review on Nano-based drug delivery system for Cancer chemoimmunotherapy","volume":"12","author":"Mu","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.intimp.2025.115013_bb0450","first-page":"14","article-title":"Recent advances in CXCL12\/CXCR4 antagonists and Nano-based drug delivery Systems for Cancer Therapy","author":"Zhao","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2025.115013_bb0455","first-page":"1973","article-title":"The application of nanoparticles in cancer immunotherapy: targeting tumor microenvironment","volume":"6","author":"Yang","year":"2021","journal-title":"Bioact Mater"},{"key":"10.1016\/j.intimp.2025.115013_bb0460","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/cas.15323","article-title":"Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell-specific liposomal siRNA delivery system","volume":"113","author":"Maishi","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.intimp.2025.115013_bb0465","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70462","article-title":"Targeting tumor endothelial cells by EGCG using specific liposome delivery system inhibits vascular inflammation and thrombosis","volume":"13","author":"Jia","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.intimp.2025.115013_bb0470","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s44321-024-00064-8","article-title":"FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4","volume":"16","author":"Bian","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.intimp.2025.115013_bb0475","doi-asserted-by":"crossref","first-page":"eabq3016","DOI":"10.1126\/sciimmunol.abq3016","article-title":"Metabolic challenges and interventions in CAR T cell therapy","volume":"8","author":"Peng","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.intimp.2025.115013_bb0480","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.7150\/ijbs.34213","article-title":"Current Progress in CAR-T cell therapy for solid Tumors","volume":"15","author":"Ma","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2025.115013_bb0485","first-page":"121","article-title":"In silico analysis of angiogenesis associated gene expression identifies angiogenic stage related profiles","volume":"1755","author":"van Beijnum","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.intimp.2025.115013_bb0490","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood-2006-02-004291","article-title":"Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature","volume":"108","author":"van Beijnum","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2025.115013_bb0495","article-title":"The critical role of endothelial cell in the toxicity associated with chimeric antigen receptor T cell therapy and intervention strategies","author":"Zhang","year":"2024","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.intimp.2025.115013_bb0500","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/gt.2013.19","article-title":"Specificity redirection by CAR with human VEGFR-1 affinity endows T lymphocytes with tumor-killing ability and anti-angiogenic potency","volume":"20","author":"Wang","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.intimp.2025.115013_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188701","article-title":"Directing CAR T cells towards the tumor vasculature for the treatment of solid tumors","volume":"1877","author":"Akbari","year":"2022","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.intimp.2025.115013_bb0510","first-page":"5","article-title":"CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth","author":"Zhuang","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2025.115013_bb0515","doi-asserted-by":"crossref","first-page":"1846926","DOI":"10.1080\/2162402X.2020.1846926","article-title":"Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trial","volume":"9","author":"Dai","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.intimp.2025.115013_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188441","article-title":"Immunotherapy for advanced hepatocellular carcinoma, where are we?","volume":"1874","author":"Zhang","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.intimp.2025.115013_bb0525","article-title":"Mechanisms and clinical trials of hepatocellular carcinoma immunotherapy","volume":"12","author":"Huang","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.intimp.2025.115013_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100702","article-title":"New insights into the pharmacological, immunological, and CAR-T cells approaches in the treatment of hepatocellular carcinoma","volume":"51","author":"Dal Bo","year":"2020","journal-title":"Drug Resist. Updat."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925010033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925010033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T19:46:44Z","timestamp":1775764004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925010033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":106,"alternative-id":["S1567576925010033"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115013","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of tumor-associated endothelial cells in malignant progression and immune evasion of liver cancer","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115013"}}